Date published: 2026-3-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

CTTNBP2NL Activators

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin elevates intracellular cAMP levels, potentially affecting signaling pathways associated with CTTNBP2NL.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 selectively inhibits p38, which may influence the equilibrium of signaling pathways related to CTTNBP2NL.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 increases intracellular calcium levels, which could activate calcium-dependent signaling pathways linked to CTTNBP2NL.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine, a broad-spectrum kinase inhibitor, might selectively activate CTTNBP2NL pathways by alleviating kinase-mediated inhibition.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 inhibits MEK1, which may promote pathways favorable to CTTNBP2NL within the MAPK pathway.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Calyculin A inhibits protein phosphatase 1 (PP1), affecting cellular processes linked to CTTNBP2NL.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that may impact pathways associated with CTTNBP2NL through PI3K modulation.

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
$71.00
$202.00
18
(1)

SB216763 inhibits GSK-3, potentially influencing pathways relevant to CTTNBP2NL function.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

KN-93 inhibits CaMKII, which might impact calcium-dependent signaling pathways linked to CTTNBP2NL.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits the mTOR pathway, potentially affecting mTOR-mediated processes indirectly related to CTTNBP2NL.